glp-1 news november 6 2025 🚨 Breaking in Obesity Care! 🚨 President Trump just announced major deals with Eli Lilly and Novo Nordisk — the makers of Mounjaro, Zepbound, Wegovy, and Ozempic — to slash weight Novo Nordisk, Lilly strike deal

Tirzepatide : Approved in 2022 (Mounjaro) and 2024 (Zepbound), its NCE exclusivity runs to May 2027, delaying generic filings until 2026

Some insurance plans may require prior authorization or additional documentation from the healthcare provider to approve Semaglutide GLP-1 treatment

With the help of another family of enzymes (glutathione-S-transferases), glutathione has the ability to plant itself on toxins, flagging them as hazardous

But they'll get the last laugh because I'll be dead, well fed, but dead, and they'll still be going

If youre ready to start purifying GST-fusion proteins, or need more information about this powerful experimental approach, check those links out